USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
U.S. Asthma/COPD Market
15-Apr-2011
North America
Market Research
N85C-01-00-00-00
HC02171-NA-MR_07790
This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.
U.S. Asthma/COPD Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Asthma Disease Overview
- COPD Disease Overview
- Market Engineering Measurements
- Patient Forecasts - Asthma
- Patient Forecasts - COPD
- Total Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Bronchodilators Product Analysis
- Short-Acting Bronchodilators Product Analysis
- Long-Acting Bronchodilators Product Analysis
- Anticholinergics Product Analysis
- Combination Bronchodilators Product Analysis
Anti-Inflammatories Product Analysis
- Inhaled Corticosteroids Product Analysis
- Anti-Leukotriene Product Analysis
- Monoclonal Antibodies Product Analysis
Combination Therapies Product Analysis
- Combination Therapies Product Analysis
Pipeline Analysis
- Phase III Pipeline Analysis
Total Market Forecasts
Revenue Forecasts for Bronchodilators
Revenue Forecasts for Anti-Inflammatories
Revenue Forecasts for Combination Therapies
Competitive Analysis
Market Share Analysis
- Revenue Forecasts for Total Asthma/COPD Market
Decision Support Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.